Suven Pharmaceuticals Limited (SUVENPHAR.NS)

INR 1222.2

(-1.95%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 22.54 Billion 19.65 Billion 18.29 Billion 14.74 Billion 11.72 Billion 7.83 Billion
Total Current Assets 12.63 Billion 10.11 Billion 11.27 Billion 5.64 Billion 3.91 Billion 3.89 Billion
Cash And Short Term Investments 8.24 Billion 4.87 Billion 5.25 Billion 1.87 Billion 423.71 Million 179.66 Million
Cash and Cash Equivalents 504.98 Million 648.02 Million 445.63 Million 71.82 Million 116.95 Million 109.03 Million
Short Term Investments 7.73 Billion 4.22 Billion 4.81 Billion 1.8 Billion 306.76 Million 70.63 Million
Net Receivables 1.34 Billion 1.11 Billion 3.17 Billion 1.75 Billion 1.74 Billion 2.11 Billion
Inventory 2.31 Billion 3.12 Billion 2.83 Billion 2.01 Billion 1.74 Billion 1.57 Billion
Other Current Assets 731.06 Million 998.72 Million 14.56 Million 153 Thousand -2000.00 34.43 Million
Total Non-Current Assets 9.9 Billion 9.54 Billion 7.01 Billion 9.09 Billion 7.81 Billion 3.93 Billion
Net PPE 7.86 Billion 7.66 Billion 5.61 Billion 5.34 Billion 4.55 Billion 3.79 Billion
Good Will And Intangible Assets 619.25 Million 621.9 Million 22.36 Million 25.9 Million 27.96 Million 26.85 Million
Good Will 602.58 Million 602.58 Million - - - -
Intangible Assets 619.25 Million 621.9 Million 22.36 Million 25.9 Million 27.96 Million 26.85 Million
Long-Term Investments 1.39 Billion 1.17 Billion 1.17 Billion 3.61 Billion 3.07 Billion 705 Thousand
Tax Assets 44.76 Million 59.34 Million 203.71 Million 50.13 Million 19.43 Million -
Other Non Current Assets -22.39 Million 32.51 Million -1000.00 59.92 Million 133.12 Million -3.82 Billion
Other Assets - - - - - -
Total Liabilities 2.03 Billion 2.3 Billion 3.02 Billion 2.93 Billion 3.28 Billion 1.92 Billion
Total Current Liabilities 1.06 Billion 1.58 Billion 2.1 Billion 2.19 Billion 2 Billion 1.57 Billion
Account Payables 423.57 Million 651.64 Million 1.05 Billion 829.31 Million 710.55 Million 535.74 Million
Tax Payables - 2.93 Million 36.42 Million - 52.53 Million 1.09 Million
Short Term Debt 437.6 Million 650.76 Million 682.23 Million 1.06 Billion 944.42 Million 827.93 Million
Deferred Revenue 6.88 Million 255.72 Million 340.7 Million 278.54 Million 309.65 Million 159.69 Million
Other Current Liabilities 200.88 Million 29.52 Million 20.99 Million 22.56 Million 39.08 Million 52.71 Million
Total Non Current Liabilities 965.27 Million 717.93 Million 921.12 Million 739.08 Million 1.27 Billion 351.17 Million
Long-Term Debt 212.35 Million 52.64 Million 289.03 Million 363.29 Million 917.64 Million -
Deferred Revenue Non Current -1.00 128.59 Million 373.34 Million 422.36 Million 83.14 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 105 Million -45.64 Million -284.4 Million -355.9 Million 1000.00 59.45 Million
Other Liabilities 1.00 - - - - -
Total Equity 20.5 Billion 17.35 Billion 15.27 Billion 11.8 Billion 8.44 Billion 5.9 Billion
Stock Holders Equity 20.5 Billion 17.35 Billion 15.27 Billion 11.8 Billion 8.44 Billion 5.9 Billion
Common Stock 254.56 Million 254.56 Million 254.56 Million 254.56 Million 127.28 Million 127.28 Million
Retained Earnings 17.65 Billion 14.65 Billion 12.72 Billion 9.36 Billion 6.15 Billion 3.9 Billion
Accumulated other comprehensive income 1.5 Billion 1.34 Billion 1.19 Billion 1.09 Billion 942.88 Million 642.76 Million
Common Stock Equity 20.5 Billion 17.35 Billion 15.27 Billion 11.8 Billion 8.44 Billion 5.9 Billion
Capital Lease Obligation 212.35 Million 11.78 Million 15.53 Million 18.07 Million 9.16 Million -
Total Investments 9.13 Billion 1.23 Billion 1.17 Billion 3.61 Billion 3.12 Billion 44.44 Million
Total Debt 649.96 Million 703.4 Million 971.27 Million 1.43 Billion 1.86 Billion 827.93 Million
Net Debt 144.97 Million 55.38 Million 525.63 Million 1.35 Billion 1.74 Billion 718.9 Million

Balance Sheet Charts